153 related articles for article (PubMed ID: 10037191)
1. Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma.
Sugiyama T; Sadzuka Y
Clin Cancer Res; 1999 Feb; 5(2):413-6. PubMed ID: 10037191
[TBL] [Abstract][Full Text] [Related]
2. Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma.
Sugiyama T; Sadzuka Y
Cancer Lett; 1998 Nov; 133(1):19-26. PubMed ID: 9929156
[TBL] [Abstract][Full Text] [Related]
3. Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents.
Sugiyama T; Sadzuka Y
Biochim Biophys Acta; 2003 Dec; 1653(2):47-59. PubMed ID: 14643924
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cancer chemotherapy by green tea.
Sadzuka Y; Sugiyama T; Hirota S
Clin Cancer Res; 1998 Jan; 4(1):153-6. PubMed ID: 9516964
[TBL] [Abstract][Full Text] [Related]
5. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
6. Theanine, a specific glutamate derivative in green tea, reduces the adverse reactions of doxorubicin by changing the glutathione level.
Sugiyama T; Sadzuka Y
Cancer Lett; 2004 Aug; 212(2):177-84. PubMed ID: 15279898
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of doxorubicin concentration in the M5076 ovarian sarcoma cells by cucurbitacin E co-treatment.
Sadzuka Y; Hatakeyama H; Sonobe T
Int J Pharm; 2010 Jan; 383(1-2):186-91. PubMed ID: 19732815
[TBL] [Abstract][Full Text] [Related]
8. Membrane transport and antitumor activity of pirarubicin, and comparison with those of doxorubicin.
Sugiyama T; Sadzuka Y; Nagasawa K; Ohnishi N; Yokoyama T; Sonobe T
Jpn J Cancer Res; 1999 Jul; 90(7):775-80. PubMed ID: 10470291
[TBL] [Abstract][Full Text] [Related]
9. [Glutamate transporter mediated increase of antitumor activity by theanine, an amino acid in green tea].
Sadzuka Y; Yamashita Y; Kishimoto S; Fukushima S; Takeuchi Y; Sonobe T
Yakugaku Zasshi; 2002 Nov; 122(11):995-9. PubMed ID: 12440157
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of theanine is connected with theanine metabolism by any enzyme, not only drug metabolizing enzymes.
Sadzuka Y; Sugiyama T; Nagamine M; Umegaki K; Sonobe T
Food Chem Toxicol; 2006 Feb; 44(2):286-92. PubMed ID: 16140449
[TBL] [Abstract][Full Text] [Related]
11. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model.
te Velde EA; Vogten JM; Gebbink MF; van Gorp JM; Voest EE; Borel Rinkes IH
Br J Surg; 2002 Oct; 89(10):1302-9. PubMed ID: 12296902
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
[TBL] [Abstract][Full Text] [Related]
14. [Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
Akamatsu K; Endo K; Tsunenari T; Matsumoto T; Kaiho S; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Gan To Kagaku Ryoho; 1992 Feb; 19(2):229-35. PubMed ID: 1736835
[TBL] [Abstract][Full Text] [Related]
15. [Antitumor activity and toxicity of combined doxorubicin and disodium salt of methylene-1,1-diphosphonic acid].
Stukov AN; Mironiuk TN; Kon'kov SA; Krylova IM; Reztsova VV; Filov VA; Ivin BA
Vopr Onkol; 1998; 44(1):100-2. PubMed ID: 9578741
[TBL] [Abstract][Full Text] [Related]
16. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y
Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330
[TBL] [Abstract][Full Text] [Related]
17. Screening of biochemical modulator by tumor cell permeability of doxorubicin.
Sadzuka Y; Hatakeyama H; Daimon T; Sonobe T
Int J Pharm; 2008 Apr; 354(1-2):63-9. PubMed ID: 18054183
[TBL] [Abstract][Full Text] [Related]
18. Anserine induced advantage effects on the antitumor activity of doxorubicin.
Sadzuka Y; Sonobe T
Food Chem Toxicol; 2007 Jun; 45(6):985-9. PubMed ID: 17240507
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy of S-1 with selective cyclooxygenase-2 inhibitor for liver metastasis of colorectal carcinoma.
Tachimori A; Yamada N; Amano R; Ohira M; Hirakawa K
Anticancer Res; 2008; 28(2A):629-38. PubMed ID: 18507001
[TBL] [Abstract][Full Text] [Related]
20. Inhibited growth of a reticulum cell sarcoma (M5076) induced in vitro and in vivo by macrophage-activating agents.
Talmadge JE; Hart IR
Cancer Res; 1984 Jun; 44(6):2446-51. PubMed ID: 6372993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
